ClinicalTrialsFinder

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Clinical Trials in Toronto, Ontario

1 recruitingToronto, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 3

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Intellia Therapeutics1,200 enrolled132 locationsNCT06128629